Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Abbott Laboratories $1.3 billion notes offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Abbott Laboratories of $650 million aggregate principal amount of 1.150% notes due 2028 and $650…
Amdocs $650 million notes offering
Davis Polk advised Amdocs Limited on its $650 million SEC-registered debt offering of 2.583% notes due 2030.   Amdocs Limited is a leading software and services provider to…
Danske Bank abbreviated debt exchange offer
Davis Polk advised the dealer managers in connection with Danske Bank A/S’s offer to exchange any and all of its outstanding 5.000% non-preferred senior notes due 2022 for its newly issued…
Merck $4.5 billion notes offering
Davis Polk advised the representatives of the underwriters, in connection with the offering of $4.5 billion aggregate principal amount of notes issued by Merck & Co., Inc. The…
Viasat $400 million senior notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Viasat, Inc. of $400 million aggregate principal amount of its 6.500%…
Back to top